Imexab(SA)

BE 0442.111.548

	2023		2022		2021		2020
Profit/Loss Section 9904 Profit/Loss of the financial year (after taxes on result) (+/-)	€ 1,931,534	3413 %	€ 54,987	12 %	€ 48,955	1819 %	€ -2,847
Equity Section 10/15 Equity consists of capital, capital reserves and earnings that remain within the company. These are fully owned by the company and are at its disposal to cover its risks. The better the ratio between equity and debts, the more solvent a company is. A positive equity ratio is important. A negative equity ratio (because of accumulated losses) is a severe warning sign that the continuity of the company may be threatened.	€ 2,750,049	236 %	€ 818,515	7 %	€ 763,528	7 %	€ 714,573
Gross margin Section 9900 Gross margin or added value is net sales minus the direct costs of the goods sold. In other words: sales invoices minus purchase invoices. A negative gross margin is a warning sign especially when occurring over several years. It may indicate that the company has insufficient means to cover internal costs like salaries, etc.	€ 2,594,756	1567 %	€ 155,653	-2 %	€ 158,689	104 %	€ 77,878

	Date	Publication
	03-07-2025	Resignations, Appointments (FR)
	21-06-2024	Resignations, Appointments (FR)
	23-01-2024	Articles of Association (Translation, Coordination, Other Modifications,...) (FR)
	15-06-2021	Resignations, Appointments (FR)
	24-03-2020	Registered Office (FR)

What is the enterprise number of Imexab?

The enterprise number of Imexab is BE0442111548.

When was Imexab founded?

Imexab was founded on 28-09-1990.

What is the address of Imexab?

The current registered office of Imexab is located at Avenue Ernestine 1, 1050 Ixelles.

When was the last time Imexab filed their annual financial statements?

The most recent financial statements of Imexab were filed on 20-08-2024. You can view them here.

How many employees does Imexab have?

There are currently no employees working at Imexab or no workforce information is available.

What is the annual turnover of Imexab?

At the time of its most recent financial statements, Imexab did not publish any turnover figures. Imexab reported a gross margin of €2,594,756.00.